Nq Hcif Gp
Latest statistics and disclosures from Nq Hcif Gp's latest quarterly 13F-HR filing:
- Top 5 stock holdings are RVNC, and represent 100.00% of Nq Hcif Gp's stock portfolio.
- Nq Hcif Gp has $50M in assets under management (AUM), dropping by 19.19%.
- Central Index Key (CIK): 0001598203
Portfolio Holdings for Nq Hcif Gp
Nq Hcif Gp holds 1 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Revance Therapeutics (RVNC) | 100.0 | $50M | 3.1M | 16.21 |
|
Past Filings by Nq Hcif Gp
SEC 13F filings are viewable for Nq Hcif Gp going back to 2014
- Nq Hcif Gp 2016 Q3 filed Oct. 27, 2016
- Nq Hcif Gp 2016 Q2 filed July 26, 2016
- Nq Hcif Gp 2016 Q1 filed April 25, 2016
- Nq Hcif Gp 2015 Q4 filed Feb. 9, 2016
- Nq Hcif Gp 2015 Q3 filed Oct. 13, 2015
- Nq Hcif Gp 2015 Q2 filed Aug. 3, 2015
- Nq Hcif Gp 2015 Q1 filed April 28, 2015
- Nq Hcif Gp 2014 Q4 filed Feb. 17, 2015